NIP2 (Nek2-Interacting Protein 2), also known as centrobin, is a centrosomal protein critical for microtubule organization, spindle assembly, and centriole duplication . Antibodies targeting NIP2 are essential tools for studying its roles in cell cycle regulation, mitotic processes, and pathologies such as cancer. Research on NIP2 antibodies has revealed insights into protein localization, phosphorylation dynamics, and functional interactions with kinases like Nek2 .
NIP2 stabilizes microtubule networks and supports microtubule nucleation activity. Knockdown experiments show impaired microtubule re-growth and spindle assembly defects .
Mechanism: NIP2 phosphorylation by Nek2 regulates its mobilization to microtubules, enhancing structural stability .
NIP2 levels remain stable throughout the cell cycle but decrease slightly during G2/M phase. Depletion leads to G2/M arrest, apoptosis, and abnormal nuclear morphology .
Impact: Cells lacking NIP2 exhibit reduced viability (~50% survival at 96 hours post-transfection) .
NIP2 is a substrate of Nek2, with phosphorylation occurring at its N-terminal region (residues 1–193). This interaction modulates centrosomal NIP2 levels .
Key Evidence:
NIP2 antibodies are used in diverse experimental workflows:
Parameter | Observation |
---|---|
Microtubule re-growth | 10% of cells formed asters post-recovery . |
Cell size | Reduced by ~40% in NIP2-suppressed cells . |
Apoptosis rate | Sub-G1 population increased by 2.5-fold . |
NIP2 antibodies enable studies of centriole duplication errors linked to microcephaly and cancer . Ongoing research explores its role in BRCA2-mediated DNA repair pathways .